Puritan Medical Products Company LLC v. Copan Italia S.P.A.

2018 ME 90, 188 A.3d 853
CourtSupreme Judicial Court of Maine
DecidedJuly 3, 2018
DocketDocket: BCD–17–180
StatusPublished
Cited by10 cases

This text of 2018 ME 90 (Puritan Medical Products Company LLC v. Copan Italia S.P.A.) is published on Counsel Stack Legal Research, covering Supreme Judicial Court of Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Puritan Medical Products Company LLC v. Copan Italia S.P.A., 2018 ME 90, 188 A.3d 853 (Me. 2018).

Opinions

Concurrence:ALEXANDER, J.

HUMPHREY, J.

[¶ 1] Puritan Medical Products Company LLC appeals from a summary judgment entered in the Business and Consumer Docket ( Mulhern, J. ) in favor of Copan Italia S.p.A. on Puritan's claim that Copan violated Maine's Actions for Bad Faith Assertion of Patent Infringement statute, 14 M.R.S. §§ 8701 - 8702 (2017). Although the court granted Copan's motion for summary judgment after finding no genuine issues of material fact and determining that Copan was entitled to judgment as a matter of law, Copan filed a cross-appeal to preserve its separate argument that Puritan's claim was preempted by federal patent law. Because we conclude that Puritan's claim is preempted, we affirm the grant of summary judgment in favor of Copan on other grounds.

I. BACKGROUND

[¶ 2] Puritan and Copan both produce flocked swabs 1 that are sold throughout the world. Copan has developed, produced, and marketed flocked swabs since 2003 and currently holds patents in both Europe and the United States. Headquartered in Italy, Copan also maintains facilities in China and the United States and employs 450 people. In 2015, Copan produced over 50 million flocked swabs.

[¶ 3] Puritan also manufactures flocked swabs. Based in Guilford, Maine, Puritan employs 250 people. In 2010, Puritan applied for patents relating to flocked swabs and began producing, marketing, and selling its flocked swabs in countries where Copan holds patents.

[¶ 4] In 2011, Copan became concerned that some of Puritan's flocked swabs infringed its European and United States patents. Copan alleged that it commissioned external and performed internal examinations of Puritan's flocked swabs to compare them to Copan's patents. 2 Based on the results of that testing, Copan sent a letter to Puritan's distributor on June 8, 2011, communicating its belief that Puritan's swabs infringed Copan's patents.

[¶ 5] In 2012, Copan filed a claim against Puritan in Germany, alleging infringement of its German utility models, 3 which evolve from its European patents. Through those proceedings, Copan received additional information about the composition of Puritan's flocked swabs from tests performed by two court-appointed experts. Copan interpreted the results of the tests to confirm that Puritan's flocked swabs fall within the scope of protection afforded by some of Copan's patents. Puritan denies that the experts' findings confirmed infringement. Although aspects of the German proceedings are still pending, Copan won a utility model infringement case against Puritan in 2014 and, in 2015, one of its European patents and a utility model were confirmed to be valid.

[¶ 6] In the spring of 2015, Copan learned that Puritan's flocked swabs may have been offered as part of a bid by a distributer, GE Healthcare Life Sciences, to supply the French Gendarmerie with forensic products. Copan sent letters to GE Healthcare 4 and the French Gendarmerie, explaining that Puritan's flocked swabs may infringe upon Copan's patents. The French Gendarmerie did not accept GE Healthcare's offer.

[¶ 7] In September 2015, Puritan filed a complaint in the Superior Court in Piscataquis County against Copan pursuant to Maine's Actions for Bad Faith Assertion of Patent Infringement statute. See 14 M.R.S. §§ 8701 - 8702. Shortly thereafter, the case was transferred to the Business and Consumer Docket. Copan answered the complaint and asserted affirmative defenses, including that Puritan's claim was preempted by United States federal patent law. 5 After more than one year of discovery, Copan moved for summary judgment, arguing that federal patent law preempted Puritan's claim and, in the alternative, that the record showed no genuine issue of material fact on the merits and that it was entitled to summary judgment as a matter of law.

[¶ 8] The court granted Copan's motion for summary judgment. It concluded (1) that it had jurisdiction to consider Puritan's claim because it was not preempted by federal patent law, and (2) that there were no genuine issues of material fact and Copan was entitled to summary judgment. 6

[¶ 9] Puritan filed an appeal from the summary judgment, and Copan filed a cross-appeal, challenging the court's conclusion that Puritan's claim was not preempted by federal law. M.R. App. P. 2 (Tower 2016). 7

II. DISCUSSION

[¶ 10] We review the entry of an order for summary judgment de novo for errors of law, viewing the evidence in the light most favorable to the party against whom summary judgment was entered. See Diviney v. Univ. of Me. Sys. , 2017 ME 56 , ¶ 14, 158 A.3d 5 .

[¶ 11] Before we can reach Puritan's challenge to the trial court's grant of summary judgment, we must first decide whether federal patent law preempts Puritan's state law claim. See James v. Inhabitants of the Town of West Bath , 437 A.2d 863 , 865 n.3 (Me. 1981) (explaining that a court will decide whether a law or ordinance is preempted before addressing the substantive argument). "Federal preemption, which involves issues of statutory and constitutional interpretation, is a question of law reviewed de novo." In re Guardianship of Smith , 2011 ME 51 , ¶ 10, 17 A.3d 136 . If we conclude that Puritan's state law claim is preempted, we will not address the parties' substantive arguments on the merits of Puritan's claim. See Doe v. Portland Hous. Auth. , 656 A.2d 1200 , 1202 (Me. 1995) ; James , 437 A.2d at 865 n.3.

[¶ 12] We begin by clarifying the legal standard for federal patent law preemption and apply it to the facts presented in the parties' statements of material facts and the supporting evidentiary materials, with disputes resolved in Puritan's favor. See Scott v. Androscoggin Cty. Jail , 2004 ME 143 , ¶¶ 2, 15, 866 A.2d 88 .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Robert L. Connary v. Richard A. Shea
2024 ME 57 (Supreme Judicial Court of Maine, 2024)
Masucci v. Judy's Moody, LLC
Maine Superior, 2022
Bernard Nadeau v. Twin Rivers Paper Company, LLC
2021 ME 16 (Supreme Judicial Court of Maine, 2021)
Michael Zelman v. Andrew Zelman
2020 ME 138 (Supreme Judicial Court of Maine, 2020)
Mark W. Ogden v. Joedy Labonville
2020 ME 133 (Supreme Judicial Court of Maine, 2020)
Puritan Medical Products Company LLC v. Copan Italia S.P.A.
2018 ME 90 (Supreme Judicial Court of Maine, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
2018 ME 90, 188 A.3d 853, Counsel Stack Legal Research, https://law.counselstack.com/opinion/puritan-medical-products-company-llc-v-copan-italia-spa-me-2018.